Principles of Biomedical Sciences and Industry
Translating Ideas into Treatments
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Principles of Biomedical Sciences and Industry
Translating Ideas into Treatments
About This Book
Principles of Biomedical Sciences and Industry
Improve your product development skills to bring new ideas to biomedicine
The development of innovative healthcare products, such as biodegradable implants, biopharmaceuticals, or companion diagnostics, requires a multi-disciplinary approach that incorporates scientific evidence with novel and innovative ideas to create new and improved products and treatments. Indeed, product development and the integration of science with commercial aspects have become key challenges for scientists working in the pharmaceutical, biotech, and medtech industries.
Using a multi-pronged approach to development, Principles of Biomedical Sciences and Industry combines ideas and methodologies from four of the central areas of focus in the biomedical arena: pharmaceuticals, diagnostics, biomaterials, and medical devices. In doing so, the book covers the entire product lifecycle, from translating a scientific idea into a prototype to product development, launch, and management.
Principles of Biomedical Sciences and Industry readers will also find:
- Several case studies from the most important product categories (pharmaceuticals, diagnostics, medical devices, combination products)
- Chapters dealing with toxicology and safety risks in development, as well as regulatory approval
- Key business aspects including how to secure funding, managing intellectual property, and price regulation in the market
- An ideal resource for teachers and students that conveys the information in an easily-digestible format
Ideal for advanced students and young professionals pursuing a career in the biomedical and healthcare industries, Principles of Biomedical Sciences and Industry is an essential reference for those in pharmaceutical industry, biotechnologists, medicinal chemists, bio-engineers, pharma engineers, and management consultants.
Frequently asked questions
Information
Table of contents
- Cover
- Table of Contents
- Title Page
- Copyright
- Foreword
- About the Editors
- List of Abbreviations
- 1 Biopharmaceutical Innovation at a Glance
- 2 Pharmacology and Drug Targets – The Basis of Therapeutics
- 3 Principles and Methods of the Pharmaceutical Drug Discovery Process – From Idea over Target to a Development Candidate
- 4 Biomarkers: Definitions and Utility for Drug Development
- 5 Toxicology in Drug Development – Understanding a Drug's Toxicity and Managing Safety and Risks
- 6 Introduction to Chemistry Manufacturing and Controls – From Compound and Development Candidate to Drug
- 7 Translational Medicine – The Bridging Discipline. Role and Tools in the Drug Development Process
- 8 Decision‐Making: What are the Key Drivers Around Decision‐Making in Drug Development?
- 9 Clinical Drug Development – Clinical Characterization for Regulatory Approval
- 10 Regulatory Affairs – Communicating with Health Authorities
- 11 Regulatory Affairs in Device Development – How to Design Medical Devices Capable to Enter the Market
- 12 Market Entry and Reimbursement: Making Drugs Available for Patients After Drug Approval
- 13 Pricing in Germany – Key Learnings for Optimizing Price Potential After the Introduction of AMNOG
- 14 Project, Risk, and Portfolio Management – Managing R&D Projects Today*
- 15 Intellectual Property – How to Protect Innovation in the Biopharmaceutical Industry
- 16 Patents in the Biomedical Sciences and Industry – The Case of the Swiss Life Science Company Prionics
- 17 Pharmaceutical Business Development and Licensing – Overview of a Cross‐Functional and Multifaceted Role and Its Key Elements in Biopharmaceutical Industry
- 18 The Entrepreneur's Guide Through the Galaxy of Biotech Funding
- 19 Medical Technologies – Key Learning from Two Case Studies
- 20 Laboratory Diagnostics – Tools for Clinical Decision‐Making and Clinical Trial Endpoints
- 21 Vaccination: Towards an Improved Influenza Vaccine
- Index
- End User License Agreement